A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath.
MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results – Biotech Investments
EQS-News: MorphoSys AG / Key word(s): Half Year Report MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results 09.08.2023 / 22:01 CET/CEST The